α-defensins released into stimulated CD8+ T-cell supernatants are likely derived from residual granulocytes within the irradiated allogeneic peripheral blood mononuclear cells used as feeders

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 5, 2004, Pages 993-1005

  Zaharatos, Gerasimos J ^a   He, Tian ^a   Lopez, Peter ^a   Yu, Wenjie ^a   Yu, Jian ^a   Zhang, Linqi ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

defensin; CD8; HIV 1; Lymphocytes; Noncytolytic; Soluble

Indexed keywords

ALPHA DEFENSIN; BETA CHEMOKINE; CD8 ANTIGEN;

ARTICLE; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNALIZATION; IRRADIATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

ALPHA-DEFENSINS; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DNA, COMPLEMENTARY; GENE EXPRESSION; GRANULOCYTES; HELA CELLS; HIV-1; HL-60 CELLS; HUMANS; ISOANTIGENS; LEUKOCYTES, MONONUCLEAR; PROTEIN ARRAY ANALYSIS; VIRUS REPLICATION;

EID: 3342958765     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200408150-00001     Document Type: Article

References (53)

1. Walker CM, Moody DJ, Stites DP, et al. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986;234:1563-1566.
2. Cocchi F, DeVico AL, Garzino-Demo A, et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995;270:1811-1815.
3. Baier M, Werner A, Bannert N, et al. HIV suppression by interleukin-16. Nature. 1995;378:563.
4. Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science. 1997;278:695-698.
5. Geiben-Lynn R, Kursar M, Brown NV, et al. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines. J Virol. 2001;75:8306-8316.
6. Greco G, Mackewicz C, Levy JA. Sensitivity of human immunodeficiency virus infection to various alpha, beta and gamma chemokines. J Gen Virol 1999;80:2369-2373.
7. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today. 1996;17:217-224.
8. Mackewicz CE, Ortega H, Levy JA. Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cell Immunol. 1994;153:329-343.
9. Geiben-Lynn R, Brown N, Walker BD, et al. Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor. J Biol Chem. 2002;277:42352-42357.
10. Geiben-Lynn R, Kursar M, Brown NV, et al. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J Biol Chem. 2003;278:1569-1574.
11. Zhang L, Yu W, He T, et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 2002;298:995-1000.
12. Cao Y, Qin L, Zhang L, et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med. 1995;332:201-208.
13. Hsueh FW, Walker CM, Blackbourn DJ, et al. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Cell Immunol. 1994;159:271-279.
14. Toso JF, Chen CH, Mohr JR, et al. Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. J Infect Dis. 1995;172:964-973.
15. Le Borgne S, Fevrier M, Callebaut C, et al. CD8(+)-cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription. J Virol. 2000;74:4456-4464.
16. Chun TW, Justement JS, Moir S, et al. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies. Proc Natl Acad Sci U S A. 2001;98:253-258.
17. Agerberth B, Charo J, Werr J, et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96:3086-3093.
18. Obata-Onai A, Hashimoto S, Onai N, et al. Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int Immunol. 2002;14:1085-1098.
19. Chang TL, Francois F, Mosoian A, et al. CAF-mediated human immuno-deficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol. 2003;77:6777-6784.
20. Robinson J. Current Protocols in Cytometry. vol 1. New York: John Wiley & Sons; 1997.
21. Ganz T, Selsted ME, Szklarek D, et al. Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest. 1985;76:1427-1435.
22. Daher KA, Lehrer RI, Ganz T, et al. Isolation and characterization of human defensin cDNA clones. Proc Natl Acad Sci USA. 1988;85:7327-7331.
23. Bateman A, Singh A, Shustik C, et al. The isolation and identification of multiple forms of the neutrophil granule peptides from human leukemic cells. J Biol Chem. 1991;266:7524-7530.
24. Muller CA, Markovic-Lipkovski J, Klatt T, et al. Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation. Am J Pathol. 2002;160:1311-1324.
25. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun. 1987;55:568-571.
26. Rice WG, Ganz T, Kinkade JM Jr, et al. Defensin-rich dense granules of human neutrophils. Blood. 1987;70:757-765.
27. van Oss CJ, Bronson PM, Dinolfo EA, et al. Two methods for the removal of erythrocytes from buffy coats for the production of human leukocyte interferon. Immunol Commun. 1981;10:549-555.
28. Richard JP, Melikov K, Vives E, et al. Cell-penetrating peptides: a re-evaluation of the mechanism of cellular uptake. J Biol Chem. 2003;278:585-590.
29. Lundberg M, Johansson M. Is VP22 nuclear homing an artifact? Nat Biotechnol. 2001;19:713-714.
30. Lundberg M, Wikstrom S, Johansson M. Cell surface adherence and endocytosis of protein transduction domains. Mol Ther. 2003;8:143-150.
31. Bruhl P, Kerschbaum A, Zimmermann K, et al. Allostimulated lymphocytes inhibit replication of HIV type 1. AIDS Res Hum Retroviruses. 1996;12:31-37.
32. Pinto LA, Sharpe S, Cohen DI, et al. Alloantigen-stimulated anti-HIV activity. Blood. 1998;92:3346-3354.
33. Grene E, Pinto LA, Cohen SS, et al. Generation of alloantigen-stimulated anti-human immunodeficiency virus activity is associated with HLA-A*02 expression. J Infect Dis. 2001;183:409-416.
34. Rugeles MT, Trubey CM, Bedoya VI, et al. Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS. 2003;17:481-486.
35. Wang Y, Tao L, Mitchell E, et al. Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women. Nat Med. 1999;5:1004-1009.
36. Wang Y, Underwood J, Vaughan R, et al. Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women. Clin Exp Immunol. 2002;129:493-501.
37. Mackewicz CE, Yuan J, Tran P, et al. Alpha-defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS. 2003;17:F23-F32.
38. Tomaras GD, Greenberg ML. CD8+ T cell mediated noncytolytic inhibition of human immunodeficiency virus type I. Front Biosci. 2001;6:D575-D598.
39. Mackewicz C, Levy JA. CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retroviruses. 1992;8:1039-1050.
40. Levy JA. HIV pathogenesis and long-term survival. AIDS. 1993;7:1401-1410.
41. Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest. 1991;87:1462-1466.
42. Yang OO, Kalams SA, Trocha A, et al. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J Virol. 1997;71:3120-3128.
43. Stranford SA, Skurnick J, Louria D, et al. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci USA. 1999;96:1030-1035.
44. Levy JA, Hsueh F, Blackbourn DJ, et al. CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children. J Infect Dis. 1998;177:470-472.
45. Bollinger RC, Quinn TC, Liu AY, et al. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication. AIDS Res Hum Retroviruses. 1993;9:1067-1077.
46. Landay AL, Mackewicz CE, Levy JA. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol. 1993;69:106-116.
47. Rosok B, Voltersvik P, Larsson BM, et al. CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells. AIDS Res Hum Retroviruses. 1997;13:79-85.
48. Barker TD, Weissman D, Daucher JA, et al. Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation. J Immunol. 1996;156:4476-4483.
49. Walker CM, Thomson-Honnebier GA, Hsueh FC, et al. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol. 1991;137:420-428.
50. Chang TL, Mosoian A, Pine R, et al. A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol. 2002;76:569-581.
51. Tomaras GD, Lacey SF, McDanal CB, et al. CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc Natl Acad Sci U S A. 2000;97:3503-3508.
52. Lacey SF, Weinhold KJ, Chen CH, et al. Herpesvirus saimiri transformation of HIV type 1 suppressive CDS+ lymphocytes from an HIV type 1-infected asymptomatic individual. AIDS Res Hum Retroviruses. 1998;14:521-531.
53. Moriuchi H, Moriuchi M, Combadiere C, et al. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci USA. 1996;93:15341-15345.